Greenwich LifeSciences, Inc. (GLSI) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$19.36M | -11.2% |
| 2024 | -$17.41M | -95.8% |
| 2023 | -$8.89M | -13.6% |
| 2022 | -$7.83M | -71.2% |
| 2021 | -$4.57M | -145.3% |
| 2020 | -$1.86M | +45.6% |
| 2019 | -$3.43M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$19.36M | -11.2% |
| 2024 | -$17.41M | -95.8% |
| 2023 | -$8.89M | -13.6% |
| 2022 | -$7.83M | -71.2% |
| 2021 | -$4.57M | -145.3% |
| 2020 | -$1.86M | +45.6% |
| 2019 | -$3.43M | — |